RELTEC MD21

MD21 is a medical device for professionals in Japan. Therefore, medical insurance is available for therapy with MD21 in Japan. Indications in Japan include headaches, stiff shoulders, insomnia, and chronic constipation.

In addition to the electron supply function, MD21 has a negative voltage application function as an electric potential therapeutic device. Although many electric potential therapeutic devices are on the market around the world, we are unaware of devices with a negative voltage application function using high DC voltage like the MD21.

Since MD21 has a two-channel output, it supplies electrons into the body from two directions. The output voltage of each channel is set to be the highest among RE therapeutic devices. Therefore, we believe that MD21 has the highest electron supply capacity among RE therapeutic devices.

“Plate for output” is a plate that supplies the output electrons by the RE therapeutic device to the human body. There are two types of plates for output: “type S (standard current value)” and “type H (high current value)”. Type H can supply more electrons to the human body.

Based on our past research¹, we recommend type H for people with weakened lymphocyte immunity. MD21 is the only RE therapeutic device that allows you to choose the one that suits you from 2 plate types for output.